Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor

Genes and Development

Volumn 12, Issue 2, 1998, Pages 186-197

  Hata, Akiko ^a   Lagna, Giorgio ^b   Massagué, Joan ^a   Hemmati Brivanlou, Ali ^b  

^a Weill Cornell Medical Center

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Antagonist; BMP receptors; Mammalian cells; Smad proteins; TGF ; Xenopus

Indexed keywords

BONE MORPHOGENETIC PROTEIN; CELL PROTEIN; SMAD1; SMAD4; SMAD6; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYO; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; XENOPUS;

ANIMALIA; MAMMALIA; XENOPUS;

EID: 0031964859     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.12.2.186     Document Type: Article

References (54)

1. Asashima, M., H. Nakano, K. Shimada, K. Kinoshita, K. Ishii, H. Shibai, and N. Ueno. 1990. Mesodermal induction in early amphibian embryos by activin A (erythroid differentiation factor). Wilhelm Roux's Arch. Dev. Biol. 198: 330-335.
2. Attisano, L., J.L. Wrana, E. Montalvo, and J. Massagué. 1996. Activation of signaling by the activin receptor complex. Mol. Cell. Biol. 16: 1066-1073.
3. Baker, J. and R.M. Harland. 1996. A novel mesoderm inducer, mMadr-2, functions in the activin signal transduction pathway. Genes & Dev. 10: 1880-1889.
4. Chen, X., M.J. Rubock, and M. Whitman. 1996. A transcriptional partner of MAD proteins in TGF-β signalling. Nature 383: 691-696.
5. Eppert, K., S.W. Scherer, H. Ozcelik, R. Pirone, P. Hoodless, H. Kim, L.-C. Tsui, B. Bapat, S. Gallinger, I.L. Andrulis, G.H. Thomsen, J.L. Wrana, and L. Attisano. 1996. MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 86: 543-552.
6. Graff, J.M. 1997. Embryonic patterning: to BMP or not to BMP, that is the question. Cell 89: 171-174.
7. Graff, J.M., R.S. Thies, J.J. Song, A.J. Celeste, and D.A. Melton. 1994. Studies with a Xenopus BMP Receptor suggest that ventral mesoderm-inducing signals override dorsal signals in vivo. Cell 79: 169-179.
8. Graff, J.M., A. Bansal, and D.A. Melton. 1996. Xenopus Mad proteins transduce distinct subsets of signals for the TGFβ superfamily. Cell 85: 479-487.
9. Hahn, S.A., M. Schutte, A.T.M.S. Hoque, C.A. Moskaluk, L.T. da Costa, E. Rozenblum, C.L. Weinstein, A. Fischer, C.J. Yeo, R.H. Hruban, and S.E. Kern. 1996. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271: 350-353.
10. Hata, A., R.S. Lo, D. Wotton, G. Lagna, and J. Massagué. 1997. Mutations increasing autoinhibition inactivate tumour suppressors Smad2 and Smad4. Nature 388: 82-87.
11. Hayashi, H., S. Abdollah, Y. Qiu, J. Cai, Y. Xu, B.W. Grinnell, M.A. Richardson, J.N. Topper, M.A. Gimbrone, Jr., J.L. Wrana, and D. Falb. 1997. The MAD-related protein Smad7 associates with the TGFβ receptor and functions as an antagonist of TGFβ signaling. Cell 89: 1165-1173.
12. Hemmati-Brivanlou, A. and D.A. Melton. 1992. A truncated activin receptor inhibits mesoderm induction and formation of axial structures in Xenopus embryos. Nature 359: 609-614.
13. Hemmati-Brivanlou, A., J.R. de la Torre, C. Holt, and R.M. Harland. 1991. Cephalic expression and molecular characterization of Xenopus En-2. Development 111: 715-724.
14. Hemmati-Brivanlou, A., O.G. Kelly and D.A. Melton. 1994. Follistatin, an antagonist of activin is expressed in the Spemann organizer and displays direct neuralizing activity. Cell 77: 283-295.
15. Hogan, B.L.M. 1996. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes &. Dev. 10: 1580-1594.
16. Hoodless, P.A., T. Haerry, S. Abdollah, M. Stapleton, M.B. O'Connor, L. Attisano, and J.L. Wrana. 1996. MADR1, a MAD-related protein that functions in BMP2 signalling pathways. Cell 85: 489-500.
17. Imamura, T., M. Takase, A. Nishihara, E. Oeda, J. Hanai, M. Kawabata, and K. Miyazono. 1997. Smad6 inhibits signalling by the TGF-β superfamily. Nature 389: 622-626.
18. Kretzschmar, M., F. Liu, A. Hata, J. Doody, and J. Massagué. 1997. The TGF-β family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase. Genes & Dev. 11: 984-995.
19. Lagna, G., A. Hata, A. Hemmati-Brivanlou, and J. Massagué. 1996. Partnership between DPC4 and SMAD proteins in TGFβ signalling pathways. Nature 383: 832-836.
20. Lechleider, R.J., M.P. de Caestecker, A. Dehejia, M.H. Polymeropoulos, and A.B. Roberts. 1996. Serine, phosphorylation, chromosomal localization and TGFβ signal transduction by human bsp-1. J. Biol. Chem. 271: 17617-17620.
21. Liu, F., A. Hata, J. Baker, J. Doody, J. Cárcamo, R. Harland, and J. Massagué. 1996. A human Mad protein acting as a BMP-regulated transcriptional activator. Nature 381: 620-623.
22. Liu, F., C. Puponnot, and J. Massagué. 1997. Dual role of the Smad4/DPC4 tumor suppressor in TGFβ-inducible transcriptional complexes. Genes & Dev. 11: 3157-3167.
23. Macias-Silva, M., S. Abdollah, P.A. Hoodless, R. Pirone, L. Attisano, and J.L. Wrana. 1996. MADR2 is a substrate of the TGFβ receptor and phosphorylation is required for nuclear accumulation and signaling. Cell 87: 1215-1224.
24. Massagué, J., A. Hata, and F. Liu. 1997. TGF-β signalling through the Smad pathway. Trends Cell Biol. 7: 187-192.
25. Massagué, J. and F. Weis-Garcia. 1996. Serine/threonine kinase receptors: Mediators of TGF-β family signals. In Cancer Surveys (ed. T. Pawson and P. Parker), pp. 41-64. Imperial Cancer Research Fund, London, UK.
26. Nakao, A., M. Afrakhte, A. Morén, T. Nakayama, J.L. Christian, R. Heuchel, S. Itoh, M. Kawabata, N.-E. Heldin, C.-H. Heldin, and P. ten Dijke. 1997. Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling. Nature 389: 631-635.
27. Newfeld, S.J., E.H. Chartoff, J.M. Graff, D.M. Melton, and W.M. Gelbart. 1996. Mothers against dpp encodes a conserved cytoplasmic protein required in DPP/TGFβ responsive cells. Development 122: 2099-2108.
28. Riggins, G.J., K.W. Kinzler, B. Vogelstein, and S. Thiagalingam. 1997. Frequency of Smad gene mutations in human cancers. Cancer Res. 57: 2578-2580.
29. Sasai, Y., B. Lu, H. Steinbeisser, D. Geissert, L.K. Gont, and E.M. De Robertis. 1994. Xenopus chordin: A novel dorsalizing factor activated by organizer-specific homeobox genes. Cell 79: 779-790.
30. Sasai, Y., B. Lu, H. Steinbeisser, and E.M. De Robertis. 1995. Regulation of neural induction by the Chd and Bmp-4 antagonistic patterning signals in Xenopus. Nature 376: 333-336.
31. Shi, Y., A. Hata, R.S. Lo, J. Massagué, and N.P. Pavletich. 1997. A structural basis for mutational inactivation of the tumour suppressor Smad4. Nature 388: 87-93.
32. Smith, W.C. and R.M. Harland. 1991. Injected Xwnt-8 RNA acts early in Xenopus embryos to promote formation of a vegetal dorsalizing center. Cell 67: 753-765.
33. _. 1992. Expression cloning of noggin, a new dorsalizing factor localized to the Spemann Organizer in Xenopus embryos. Cell 70: 829-840.
34. Smith, J.C., B.M.J. Price, K. Van Nimmen, and D. Huylebroeck. 1990. Identification of a potent Xenopus mesoderm-inducing factor as a homologue of activin A. Nature 345: 729-731.
35. Suzuki, A., R.S. Thies, N. Yamaji, J.J. Song, J.M. Wozney, K. Murakami, and N. Ueno. 1994. A truncated bone morphogenetic protein receptor affects dorsal-ventral patterning in the early Xenopus embryo. Proc. Natl. Acad. Sci. 91: 10255-10259.
36. Suzuki, A., C. Chang, J.M. Yingling, X.-F. Wang, and A. Hemmati-Brivanlou. 1997. Smad5 induces ventral fates in Xenopus embryo. Dev. Biol. 184: 402-405.
37. ten Dijke, P., K. Miyazono, and C.H. Heldin. 1996. Signaling via hetero-oligomeric complexes of type I and type II serine/ threonine kinase receptors. Curr. Opin. Cell Biol. 8: 139-145.
38. Thomsen, G. 1996. Xenopus mothers against decapentaplegic is an embryonic ventralizing agent that acts downstream of the BMP-2/4 receptor. Development 122: 2359-2366.
39. Thomsen, G., T. Woolf, M. Whitman, S. Sokol, J. Vaughan, W. Vale, and D.A. Melton. 1990. Activins are expressed early in Xenopus embryogenesis and can induce axial mesoderm and anterior structures. Cell 63: 485-493.
40. Topper, J.N., J. Cai, Y. Qiu, K.R. Anderson, Y. Xu, J. Deeds, R. Feeley, C. Gimeno, E. Woolf, O. Tayber, G. Mays, B.A. Sampson, F. Schoen, M. Gimbrone, and D. Falb. 1997. Vascular MADs: two novel MAD-related genes selectively inducible by flow in human vascular endothelium. Proc. Natl. Acad. Sci. 94: 9314-9319.
41. Tsuneizumi, K., T. Nakayama, Y. Kamoshida, T.B. Kornberg, J.L. Christian, and T. Tabata. 1997. Daughters against dpp modulates dpp organizing activity in drosophila wing development. Nature 389: 627-631.
42. Turner, D.L. and H. Weintraub. 1994. Expression of achaetescute homolog 3 in Xenopus embryos converts ectodermal cells to a neural fate. Genes &. Dev. 8: 1434-1447.
43. van den Eijnden-Van Raaij, A.J.M., E.J.J. van Zoelent, K. van Nimmmen, C.H. Coster, G.T. Snoek, A.J. Durston, and D. Huylebrock. 1990. Activin-like factor from Xenopus laevis cell line responsible for mesoderm induction. Nature 345: 732-734.
44. Watanabe, T.K., M. Suzuki, Y. Omori, H. Hishigaki, M. Horie, N. Kanemoto, T. Fujiwara, Y. Nakamura, and E. Takahashi. 1997. Cloning and characterization of a novel member of the human Mad gene family (MADH6). Genomics 42: 446-451.
45. Wieser, R., J.L. Wrana, and J. Massagué. 1995. GS domain mutations that constitutively activate TβR-I, the downstream signaling component in the TGF-β receptor complex. EMBO J. 14: 2199-2208.
46. Wilson, P.A. and A. Hemmati-Brivanlou. 1995. Induction of epidermis and inhibition of neural fate by Bmp-4. Nature 376: 331-333.
47. _. 1997. Vertebrate neural induction: Inducers, inhibitors, and a new synthesis. Neuron 18: 699-710.
48. Wilson, P.A., G. Lagna, A. Suzuki, and A. Hemmati-Brivanlou. 1997. Concentration-dependent patterning of the Xenopus extoderm by BMP4 and its signal transducer Smad1. Development 124: 3177-3184.
49. Wu, R.-Y., Y. Zhang, X.-H. Feng, and R. Derynck. 1997. Heteromeric and homomeric interacions correlate with signaling activity and functional cooperativity of Smad3 and Smad4/ DPC4. Mol. Cell. Biol. 17: 2521-2528.
50. Xu, R.H., J. Kim, M. Taira, S. Zhan, D. Sredni, and H.F. Kung. 1995. A dominant negative bone morphogenetic protein 4 receptor causes neuralization in Xenopus ectoderm. Biochem. Biophys. Res. Commun. 212: 212-219.
51. Yingling, J.M., P. Das, C. Savage, C. Zhang, R.W. Padgett, and X.-F. Wang. 1996. Mammalian Dwarfins are phosphorylated in response to TGF-β and are implicated in control of cell growth. Proc. Natl. Acad. Sci. 93: 8940-8944.
52. Zhang, Y., X.-H. Feng, R.-Y. Wu, and R. Derynck. 1996. Receptor-associated Mad homologues synergize as effectors of the TGFβ response. Nature 383: 168-172.
53. Zhang, Y., T. Musci, and R. Derynck. 1997. The tumor suppressor Smad4/DPC4 as a central mediator of Smad function. Curr. Biol. 7: 270-276.
54. Zimmerman, L., J. De Jesus-Escobar, and R. Harland. 1996. The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell 86: 599-606.